INS and cancer: In addition, insulin mediates insulin receptors, up-regulates MMP-2 expression, stimulates insulin receptor substrate-1 (IRS-1), and then activates the PI3K/AKT and MAPK signaling pathways to promote cancer cell proliferation and enhance cancer cell migration ability (129).